Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2162436 | 0.65 | KDM4E (0.42) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL2210364 | 0.61 | KDM4E (0.49) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL26611966 | 0.55 | L3MBTL1 (0.31) | — | |
| Fluoxidine SCHEMBL11601291 | 0.55 | — | — | |
| SCHEMBL12635219 | 0.55 | — | — | |
| SCHEMBL15109875 | 0.54 | QPCT (0.33) | — | |
| Purine SCHEMBL28150963 | 0.54 | — | — | |
| SCHEMBL916879 | 0.52 | POLB (0.44) | ALDH1A1HPGD | |
| SCHEMBL7561735 | 0.52 | — | — | |
| SCHEMBL12320643 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968556-B2 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | SIGNAL PHARMACEUTICALS, LLC (US) | 2011-06-28 | — | — | US | claimed |
| US-20140301947-A1 | METHODS TO PREDICT BINDING AFFINITY OF TSPO IMAGING AGENTS TO TSPO | IMPERIAL INNOVATIONS LIMITED (GB) | 2014-10-09 | — | — | US | disclosed |
| EP-2718464-A1 | METHODS TO PREDICT BINDING AFFINITY OF TSPO IMAGING AGENTS TO TSPO | Imperial Innovations Limited (GB) | 2014-04-16 | — | — | EP | disclosed |
| US-8501735-B2 | N-containing heteroaryl derivatives as JAK3 kinase inhibitors | PALAU PHARMA, S.A. (ES) | 2013-08-06 | — | — | US | disclosed |
| US-20130131038-A9 | N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS | VECTURA LIMITED (GB) | 2013-05-23 | — | — | US | disclosed |
| WO-2012168697-A1 | METHODS TO PREDICT BINDING AFFINITY OF TSPO IMAGING AGENTS TO TSPO | IMPERIAL INNOVATIONS LIMITED (GB) | 2012-12-13 | — | — | WO | disclosed |
| US-20120245140-A1 | N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS | ALMANSA ROSALES CARMEN (ES) | 2012-09-27 | — | — | US | disclosed |
| WO-2007103162-A2 | STRUCTURE BASED DRUG DESIGN OF STEROIDOGENESIS INHIBITORS | SAMARITAN PHARMACEUTICALS, INC. (US) | 2007-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140301947-A1 | METHODS TO PREDICT BINDING AFFINITY OF TSPO IMAGING AGENTS TO TSPO | TSPO, GPR174, TSG101 | KDM4E 4857/4885ALDH1A1 2681/4885HPGD 2051/4885 |
| US-20120245140-A1 | N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS | JAK3, JAK2, JAK1 | KDM4E 2056/4885ALDH1A1 3830/4885HPGD 2242/4885 |
| US-20130131038-A9 | N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS | JAK3, JAK2, JAK1 | KDM4E 2056/4885ALDH1A1 3830/4885HPGD 2242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.